IM Cannabis Corp is a Canada-based international medical cannabis company. It offers government-licensed cannabis products, from generic to GMP-certified and pharmaceutical-grade, for both wholesale and retail clients. The majority of its revenues are generated from sales of medical cannabis products to customers in Israel, followed by Germany.

IM Cannabis

Medical cannabis company IM Cannabis Corp. (CSE:<a class="ticker" href="/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>) made its debut on the NASDAQ Capital Market on Monday becoming the first Israeli cannabis company to do so.

Shares experienced volatility on decent volume, closing the day up almost 5%. At the time of the writing of this article on Tuesday, shares were up by 8%.

In an email to Benzinga, IM Cannabis CEO Oren Shuster said he and his team are &ldquo;extremely proud&rdquo; to be the first Israeli medical cannabis operator to join the NASDAQ capital market &ldquo;along with a select group of leading cannabis companies.&quot; He added:

&ldquo;By joining NASDAQ, IMC provides American investors with access and a gateway to investments in the emerging European and Israeli cannabis markets where we have a strong presence and operations. Very few cannabis companies can boast having a decade-long experience in the medical cannabis space and we are leveraging this experience to further propel our international growth into additional high-potential markets.&quot;

Earlier this year, IM Cannabis <a href="https://www.benzinga.com/markets/cannabis/21/01/18982821/the-week-in-cannabis-dea-research-licenses-wisconsin-an-israeli-index-m-a-and-more">entered&nbsp;</a>the North American market through the acquisition of Canada-based Trichome Financial (CSE:<a class="ticker" href="/stock/TFC#CSE">TFC</a>) and its adult-use cannabis operations.

Cannabis

News

Markets

A First In Weed: Israeli Company IM Cannabis Now Trading On The Nasdaq

In a week where most stocks took a beating, cannabis equities were no exception. All major ETFs posted&nbsp;considerable losses. Over the last five trading days:

<ul>
	<li>The ETFMG Alternative Harvest ETF (NYSE:<a class="ticker" href="/stock/MJ#NYSE">MJ</a>): lost 6%.</li>
	<li>The AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="/stock/YOLO#NYSE">YOLO</a>): tumbled 8.3%.</li>
	<li>AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="/stock/MSOS#NYSE">MSOS</a>): dropped 6.3%.</li>
	<li>The Cannabis ETF (NYSE:<a class="ticker" href="/stock/THCX#NYSE">THCX</a>): slipped 7.9%.</li>
	<li>The Amplify Seymour Cannabis ETF (NYSE:<a class="ticker" href="/stock/CNBS#NYSE">CNBS</a>): fell 8.9%.</li>
	<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="/stock/SPY#NYSE">SPY</a>) was up 0.9%, after recovering from Thursday&#39;s losses on Friday afternoon.</li>
</ul>

One move that pretty much flew under the radar: Alimentation Couche-Tard Inc., owner of Circle K, boosted its stake in Canadian cannabis company Fire &amp; Flower Holdings Corp. &nbsp;(OTCQX:<a class="ticker" href="/stock/FFLWF#OTCQX">FFLWF</a>), converting roughly $52 million it held in debt to equity. Following the transaction, the retail giant will own 19.9% of Fire &amp; Flower.

&ldquo;I think the move by Alimentation Couche Tard doesn&#39;t get nearly the amount of attention it should,&rdquo; Green Market Report Editor-in-Chief Debra Borchardt told Benzinga. &ldquo;Seeing a bigger move in the convenience store space towards&nbsp;cannabis should be unsettling to most cannabis companies,&rdquo; she warned, wondering if smaller producers will eventually be relegated to craft cannabis, as &ldquo;the volume players become the Budweisers and Miller beer versions of cannabis.&rdquo;

Benzinga Cannabis content is now available in Spanish on <a href="https://elplanteo.com/">El Planteo</a>. 

Houseplant, Seth Rogen and Evan Goldberg&rsquo;s cannabis and lifestyle brand, <a href="https://www.benzinga.com/markets/cannabis/21/03/19925999/houseplant-seth-rogen-and-evan-goldbergs-cannabis-brand-to-debut-in-the-us">is launching</a> in the U.S. on March 11. The brand was founded in Canada back in April 2019&nbsp;in partnership with cannabis giant Canopy Growth Corp. (NYSE:<a class="ticker" href="/stock/CGC#NYSE">CGC</a>). Since then, it has become one of the most coveted celebrity-backed brands in the cannabis industry.

In an email to Benzinga, Houseplant explained that&nbsp;Canopy will continue to be its licensee in Canada,&nbsp;but&nbsp;is not involved in the U.S. launch. In turn, Canopy launched its own CBD-infused sparkling water, dubbed Quatreau, in the U.S. as well.

<h2>Policy Moves</h2>

<ul>
	<li>Virginia lawmakers approved a bill to legalize the commercial marijuana program. The legislation allows people over the age of 21 to use cannabis, starting Jan. 1, 2024, as well as the possession of up to an ounce of cannabis.</li>
	<li>Michigan&rsquo;s Marijuana Regulatory Agency disclosed that the state&rsquo;s recreational cannabis market is opening to a new competition as of March 1.</li>
	<li>Iowa lowered penalties for those caught with small amounts of marijuana. Under Senate Study Bill 1226, which passed subcommittee by a unanimous vote, possession of under five&nbsp;grams of marijuana is considered as a simple misdemeanor for a first offense.</li>
	<li>The Mississippi House decided to go with the medical marijuana program voters approved in November, despite passing an alternative&nbsp;last month.</li>
	<li>Mexico is on the verge of legalizing marijuana. A floor vote on a bill is scheduled for&nbsp;the government&#39;s Chamber of Deputies for March 9.</li>
</ul>

<h2>Financings And M&amp;A</h2>

MariMed Inc. (OTCQX:<a class="ticker" href="/stock/MRMD#OTCQX">MRMD</a>) closed a $46 million financing facility&nbsp;with Hadron Healthcare Fund. Beacon Securities Ltd. advised the deal.&nbsp;

Schwazze, previously known as Medicine Man Technologies Inc. (OTCQX:<a class="ticker" href="/stock/SHWZ#OTCQX">SHWZ</a>), raised&nbsp;$34 million. CRW Capital Cann Holding&nbsp;LLC, an affiliate of Dye Capital, led the latest investment round, alongside&nbsp;other investors. The company also <a href="https://www.benzinga.com/markets/cannabis/21/03/19988035/schwazze-shares-bounce-on-heels-of-five-star-buds-deal-valued-at-72-3m">completed the acquisition</a> of five Colorado-based Star Buds dispensaries in a $72.3 million stock and cash deal this week.

Greenlane Holdings Inc.&nbsp;(NASDAQ:<a class="ticker" href="/stock/GNLN#NASDAQ">GNLN</a>) acquired the Eyce brand and all of Eyce assets. Eyce is a leading manufacturer of specialty silicone smoking products.

The Valens Company Inc. (TSX:<a class="ticker" href="/stock/VLNS#TSX">VLNS</a>) (OTCQX:<a class="ticker" href="/stock/VLNCF#OTCQX">VLNCF</a>) acquired Canadian edibles manufacturer LYF Food Technologies Inc. in a cash and stock transaction valued at CA$24.9 million ($19.68 million).

Forian Inc. (NASDAQ:<a class="ticker" href="/stock/FOR#NASDAQ">FOR</a>) was officially launched after the completed combination of Helix Technologies, Inc. and Medical Outcomes Research Analytics, LLC. Shares began trading on NASDAQ under the symbol &ldquo;FORA&rdquo; on March 3.

&ldquo;The increased growth of alternative therapeutics uniquely positions Forian to support both the healthcare and cannabis industries,&quot;&nbsp;CEO Dan Barton told Benzinga.&nbsp;&quot;The combination of our organization&rsquo;s significant capabilities and the commitment to invest will drive innovations to support our customers&rsquo; clinical, product development and marketing needs.&rdquo;

Terra Tech Corp. (OTCQX:<a class="ticker" href="/stock/TRTC#OTCQX">TRTC</a>) agreed to acquire Umbrla Inc.&nbsp;for an undisclosed price.

Bio-sciences company&nbsp;EXMceuticals Inc.&nbsp;(CSE:<a class="ticker" href="/stock/EXM#CSE">EXM</a>) is poised to merge with Global Cannabinoids (GC), a business-to-business (B2B) distributor of hemp oil, extract, isolates, and finished products. The combined entity will operate as Global Cannabinoids.

INDVR Brands agreed to acquire &quot;substantially all&quot; assets from Nevada-based Strainz Inc. and Colorado-based Bronnor Corp., including a processing and manufacturing facility in Denver, and three brands.

<h2>Earnings Reports</h2>

<ul>
	<li>Lowell Farms Inc. (OTCQX:<a class="ticker" href="/stock/INDXF#OTCQX">INDXF</a>)&nbsp;&mdash;&nbsp;previously known as Indus Holdings &mdash; reported quarterly revenue of $9.2 million, down 15% slip from the corresponding three-month period&nbsp;in&nbsp;2019.</li>
	<li>Choom&nbsp;Holdings Inc. (OTCQB:<a class="ticker" href="/stock/CHOOF#OTCQB">CHOOF</a>) posted its second quarter of fiscal 2021 revenue of $6.1 million, up by a whopping 350% from the same period in the prior year.</li>
	<li>Columbia Care Inc. (NEO: CCHW) (OTCQX:<a class="ticker" href="/stock/CCHWF#OTCQX">CCHWF</a>)&nbsp;released&nbsp;preliminary financial results for the fourth quarter and full-year 2020. It expects combined quarterly revenue to hover&nbsp;$81.8 million. That&#39;s&nbsp;up by 234% year-over-year.</li>
	<li>High Tide Inc.&nbsp;(OTCQB:<a class="ticker" href="/stock/HITIF#OTCQB">HITIF</a>) wrapped up fiscal 2020 with roughly CA$8 million ($6.32 million) in adjusted EBITDA and CA$83.2 million ($65.7 million) in revenue.</li>
	<li>Australis Capital&nbsp;(OTCQB:<a class="ticker" href="/stock/AUSAF#OTCQB">AUSAF</a>) reported generating $90,000 in revenue in the third quarter while posting a net loss of $19.4 million.</li>
	<li>Heritage Cannabis (OTCQX:&nbsp;HERTF) revealed its gross revenue declined by 58% year-over-year to $1.5 million in the fourth quarter of fiscal 2020. Meanwhile, its full-year gross revenue spiked 160% over the same period, reaching roughly $9.26 million.</li>
	<li>Captor Capital Corp. (CSE:<a class="ticker" href="/stock/CPTR#CSE">CPTR</a>) generated&nbsp;over $4.2 million in revenue&nbsp;for&nbsp;the quarter ending&nbsp;Dec. 31. That&rsquo;s a year-over-year increase of 99%.</li>
	<li>Ganja Goddess reported&nbsp;100% growth in revenue year-over-year; a 53% uptick in customers coming onto the platform and making purchases; and a 635% increase in revenue for cannabis products marketed to support sleep. CEO Zachary Pitts told Benzinga:&nbsp;&ldquo;With the pandemic creating a range of challenges for everyone, it&rsquo;s been interesting to see which types of products our consumers demanded the most and how their purchases are mirroring those challenges.&rdquo;</li>
</ul>

Find all the details on these and other earnings reports on <a href="https://www.benzinga.com/cannabis/earnings">Benzinga Cannabis&rsquo; Earnings Center</a>.

<h2>Data</h2>

According to&nbsp;cannabis tech company&nbsp;GemmaCert, some 45% of cannabis products worldwide are mislabelled with higher than actual THC levels. The firm studied more than 1.5 million potency scans across 35 countries on six continents.

According to analytics firm&nbsp;BDSA, total cannabis sales last year hovered $21.3 billion across the&nbsp;globe.&nbsp;

&ldquo;The cannabis industry faced numerous challenges in the past few years, none so potentially disruptive as the coronavirus pandemic in 2020,&rdquo; BDSA Chief Executive Micah Tapman said. &ldquo;Our previous forecast was conservative based on the expected economic fallout from the pandemic, but the industry not only survived, it thrived and legal cannabis gained considerable ground, exceeding our expectations in several markets.&rdquo;

<h2>Other News</h2>

IM Cannabis Corp. (CSE:<a class="ticker" href="/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>) debuted on the NASDAQ Capital Market on Monday becoming the first Israeli cannabis company to do so.

Rise dispensary owner Green Thumb Industries Inc. (CSE:<a class="ticker" href="/stock/GTII#CSE">GTII</a>) (OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) is entering the cannabis beverage market via a deal with Cann. The Chicago-based cannabis CPG company teamed up&nbsp;with the celebrity-backed cannabis beverage brand to produce and distribute its line of&nbsp;sparkling drinks in Illinois. The collaboration includes the expansion to additional markets, including New Jersey.

Nextleaf Solutions Ltd.&nbsp;(OTCQB:<a class="ticker" href="/stock/OILFF#OTCQB">OILFF</a>)&nbsp;will supply BevCanna with its Rapid Emulsion Technology by OILS. In addition, the company announced the Mexican Institute of Industrial Property granted it a patent that is key to the low-cost production of cannabis distillates. Following this approval, Nextleaf boasts the second-largest cannabis patent portfolio in Mexico.

ABSTRAX became the first terpene distributor&nbsp;to sell on the Weedmaps WP Exchange. Now, retailers and brands can enjoy same-day access to the company&#39;s extensive&nbsp;collection of both cannabis-derived (California only) and botanically-derived terpenes (throughout the U.S.). Max Koby, ABSTRAX founding partner and CEO, told Benzinga that the&nbsp;partnership will&nbsp;&quot;revolutionize the way brands interact with terpenes as they grow their product lines.&quot;

Copperstate Farms announced plans to expand its cultivation operations, doubling its production footprint to 80-acres under glass. The company already operates a 40-acre grow, believed to be the largest cannabis greenhouse in the U.S.

<h2>The METRC Issue</h2>

Since February 17, businesses throughout the state of California have been experiencing significant outages with METRC&rsquo;s external API. These outages have significantly impacted businesses that operate using software to sync relevant data back to METRC in order to maintain compliance.

Benzinga caught up with Colton Griffin, CEO of Flourish Software, which works with METRC. He explained that his clients and hundreds of other businesses across the state use this software, and this outage has caused major interruptions to how they deliver client service.

&ldquo;It&rsquo;s disheartening that these issues continue without being addressed. An external API is essential because METRC compliance is integral to maintaining business operations and state-mandated compliance tracking. This downtime prevents licensees from performing core operations such as invoicing, manufacturing and harvesting.&rdquo;

Flourish and other industry participants sent an open letter to the CDFA and the BCC, asking the California Department of Food and Agriculture (CDFA), which administers METRC, to intervene and improve the service and reliability of this service.

<h2>Executive Moves</h2>

Read all about the latest executive moves <a href="http://www.benzinga.com/markets/cannabis/21/03/20011884/cannabis-movers-shakers-nusachi-apwc-nabis-amco-wslcb-veritas-vinergy-shield-compliance-biosteel">here</a> and <a href="http://www.benzinga.com/markets/cannabis/21/03/19917487/cannabis-movers-shakers-indiva-parallel-open-book-extracts-adnant-delic-holdings">here</a>.

<h2>Top Stories Of The Week</h2>

<ul>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19884210/exclusive-panaxia-gm-talks-up-european-cannabis-market-perks-of-having-limited-competition" title="Exclusive: Panaxia GM Talks Up European Cannabis Market, Perks Of Having 'Limited Competition'">Exclusive: Panaxia GM Talks Up European Cannabis Market, Perks Of Having &#39;Limited Competition&#39;</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19778243/a-little-shatner-with-your-cannabis-how-smarty-plants-embraces-quirky-to-outshine-rival-brands" title="A Little Shatner With Your Cannabis? How Smarty Plants Embraces 'Quirky' To Outshine Rival Brands">A Little Shatner With Your Cannabis? How Smarty Plants Embraces &#39;Quirky&#39; To Outshine Rival Brands</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19921333/how-the-war-on-drugs-reinforced-structural-racism" title="How The War On Drugs Reinforced Structural Racism">How The War On Drugs Reinforced Structural Racism</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19942274/benzingas-cannabis-capital-conference-day-2-keynote-with-the-parent-companys-steve-allan" title="Benzinga's Cannabis Capital Conference Day 2 Keynote with The Parent Company's Steve Allan">Benzinga&#39;s Cannabis Capital Conference Day 2 Keynote with The Parent Company&#39;s Steve Allan</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19988297/new-cannabis-products-dosist-x-710-labs-live-resin-vapes-flower-by-edie-parkers-cbd-topicals-thc" title="New Cannabis Products: Dosist x 710 Labs Live Resin Vapes, Flower by Edie Parker's CBD Topicals, THC Gummies In Texas">New Cannabis Products: Dosist x 710 Labs Live Resin Vapes, Flower by Edie Parker&#39;s CBD Topicals, THC Gummies In Texas</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19992376/new-cannabis-products-lost-farm-chews-bella-thornes-new-strains-and-an-oral-spray" title="New Cannabis Products: Lost Farm Chews, Bella Thorne's New Strains, And An Oral Spray">New Cannabis Products: Lost Farm Chews, Bella Thorne&#39;s New Strains, And An Oral Spray</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19988122/new-cannabis-products-caliva-pax-era-vapes-patches-designed-for-women-and-a-curated-cbd-subscrip" title="New Cannabis Products: Caliva Pax Era Vapes, Patches Designed For Women, And A Curated CBD Subscription Box">New Cannabis Products: Caliva Pax Era Vapes, Patches Designed For Women, And A Curated CBD Subscription Box</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19992621/eazes-state-of-cannabis-data-report-how-consumers-reacted-to-crises-what-new-markets-can-learn" title="Eaze's 'State of Cannabis' Data Report: How Consumers Reacted To Crises, What New Markets Can Learn">Eaze&#39;s &#39;State of Cannabis&#39; Data Report: How Consumers Reacted To Crises, What New Markets Can Learn</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/19943084/higher-standards-and-kayas-cannabis-retail-experience-in-uruguay-is-a-feast-for-the-senses" title="Higher Standards And Kaya's Cannabis Retail Experience In Uruguay Is A Feast For The Senses">Higher Standards And Kaya&#39;s Cannabis Retail Experience In Uruguay Is A Feast For The Senses</a></li>
	<li><a href="https://www.benzinga.com/markets/cannabis/21/03/20030624/driven-by-stem-is-a-daas-platform-designed-for-the-future-of-the-cannabis-industry" title="Driven By Stem Is A DaaS Platform Designed For The Future Of The Cannabis Industry">Driven By Stem Is A DaaS Platform Designed For The Future Of The Cannabis Industry</a></li>
</ul>

Top Spanish stories:

<ul>
	<li><a href="https://elplanteo.com/hablamos-con-xiuhtezcatl-el-joven-rapero-y-activista-que-no-cree-en-las-fronteras/">Hablamos con Xiuhtezcatl, el Joven Rapero y Activista que No Cree en las Fronteras</a></li>
	<li><a href="https://elplanteo.com/argentina-que-dijo-alberto-fernandez-sobre-cannabis-en-su-discurso/">Argentina: Qu&eacute; Dijo Alberto Fernandez sobre Cannabis en su Discurso</a></li>
	<li><a href="https://elplanteo.com/decir-que-son-todos-chorros-sale-de-un-lugar-de-privilegio-martin-rechimuzzi-sobre-drogas-politica-y-goce/">&lsquo;Decir que Son Todos Chorros Sale de un Lugar de Privilegio&rsquo;: Mart&iacute;n Rechimuzzi sobre Drogas, Pol&iacute;tica y Goce</a></li>
	<li><a href="https://elplanteo.com/las-mejores-criptomonedas-para-invertir-en-2021/">Las Mejores Criptomonedas para Invertir en 2021</a></li>
	<li><a href="https://elplanteo.com/acciones-de-marihuana/">C&oacute;mo Invertir en Acciones de Cannabis</a></li>
	<li><a href="https://elplanteo.com/turismo-cannabico-y-desarrollo-en-latinoamerica/">Turismo Cann&aacute;bico y Desarrollo en Latinoam&eacute;rica</a></li>
	<li><a href="https://elplanteo.com/como-invertir-en-criptomonedas-en-colombia/">&iquest;C&oacute;mo Invertir en Criptomonedas en Colombia?</a></li>
	<li><a href="https://elplanteo.com/interacciones-con-medicamentos-y-efectos-adversos-de-la-marihuana/">Interacciones con Medicamentos y Efectos Adversos de la Marihuana</a></li>
</ul>

Lead image by <a href="https://www.behance.net/ilona-szentivanyi">Ilona Szentivanyi</a>. Copyright: Benzinga.

Penny Stocks

Small Cap

The Week In Cannabis: ETFs Are Down, Virginia Legalizes, Houseplant Hits The US, Big Retail Makes Moves

The Week In Cannabis: Banking, Insurance, NY, Earnings, Financings, M&A, And More

Benzinga&rsquo;s <a href="https://www.youtube.com/playlist?list=PL4k0fH8EgI3ZSvns1pymdSRwOIA-exAaA">Cannabis Insider</a> is a live daily show for cannabis investors.

On Monday&rsquo;s show, hosts <a href="https://twitter.com/patricklanebz">Patrick Lane</a> and <a href="https://elplanteo.com/author/javier-hasse/">Javier Hasse</a> discussed recent news about MAZAKALI and Satori Investment Partners&rsquo; new $20 million cannabis fund, as well as the following publicly-traded companies:

<ul>
	<li>IM Cannabis Corp. (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>)</li>
	<li>Cresco Labs Inc. (OTC:<a class="ticker" href="/stock/CRLBF#OTC">CRLBF</a>)</li>
	<li>Verano Holdings Corp. (OTC:<a class="ticker" href="/stock/VRNOF#OTC">VRNOF</a>)</li>
	<li>The Valens Company Inc. (OTC:<a class="ticker" href="/stock/VLNCF#OTC">VLNCF</a>)</li>
	<li>Planet 13 Holdings Inc. (OTC:<a class="ticker" href="/stock/PLNHF#OTC">PLNHF</a>)</li>
	<li>Curaleaf Holdings, Inc. (OTC:<a class="ticker" href="/stock/CURLF#OTC">CURLF</a>)</li>
	<li>Akerna Corp. (NASDAQ:<a class="ticker" href="/stock/KERN#NASDAQ">KERN</a>)</li>
	<li>Trulieve Cannabis Corp. (OTC:<a class="ticker" href="/stock/TCNNF#OTC">TCNNF</a>)</li>
	<li>TerrAscend Corp. (OTC:<a class="ticker" href="/stock/TRSSF#OTC">TRSSF</a>)</li>
</ul>

<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/C2Kyt3SeMOo" width="560"></iframe>

Meet The Hosts:

<ul>
	<li>Patrick Lane: <a href="https://www.youtube.com/redirect?event=video_description&amp;redir_token=QUFFLUhqbDVPZWJWYnU0OGgyUHhFdHdqQ0c0TFd2YXRtQXxBQ3Jtc0tsTlNvdDlRb0xjN2V1aGlXZ3Z1T1Q3bjA5Q1p0UXlMdmtXQlRWNUdfNnhrVVF0VE9nT3NhME1VNnBZTkx4SFZQMkJtMEZJemkwSnFhX2JXcWRROEJ3enRzZWNpZ1p3WXROX0c2QURvcTNXak9pSl9xQQ&amp;q=https%3A%2F%2Ftwitter.com%2Fpatricklanebz">https://twitter.com/patricklanebz</a>​</li>
	<li>Javier Hasse: <a href="https://www.youtube.com/redirect?event=video_description&amp;redir_token=QUFFLUhqbmp0aGZvQ2ZfejQ5MnhhZXBEdWQ5NjdOQnpmZ3xBQ3Jtc0trZU15ZmdHS2ZOSVhwYW1BTFpOcWduRWhkWm1Rakk5a1RvVEFVaXI5SHJlR0NKX0ZzRWJMY1M1RjNrX3FSc0hjOXdWOGRCWWp1VFduakJ1b2hJT2ZGTU51a1V1SjUyNGVoX1RELWVEWjRBcDZvSnBZUQ&amp;q=https%3A%2F%2Ftwitter.com%2Fjavierhasse">https://twitter.com/javierhasse</a>​</li>
</ul>

Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.

Video: Benzinga Cannabis Insider 3/22 Ft. IM Cannabis, Cresco Labs, Akerna, Trulieve, And More

Multi-country medical and recreational cannabis operator, IM Cannabis (CSE:<a class="ticker" href="/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>) continues to strategically expand in Canada with its second acquisition of 2021.

The company announced this week it reached a definitive agreement to acquire MYM Nutraceuticals and its Licensed Producer subsidiary Highland Growth.

The acquisition is expected to close before the end of 2021 and is valued at C$85 million ($67.6 million). It&#39;s intended to further expand IMC&#39;s presence in the Canadian market, broadening its premium and super-premium product portfolio for both recreational and medical cannabis customers.

The company also confirmed it intends to leverage its Canadian acquisitions of Highland Growth and JWC to fulfill international demand for premium indoor-grown cannabis products, especially in Israel and Germany, where IMC has a strong presence and patient base.

&quot;This acquisition is consistent with our M&amp;A practice of acquiring high-potential and profitable cannabis companies that complement our current operations, contribute to our financial strength and increase shareholders value,&quot; Oren Shuster, the CEO of IM Cannabis told Benzinga. &quot;Our long-term goal is to become one of the global leaders in the recreational and medical cannabis sector and this acquisition is another important milestone on this path.&quot;

<a href="https://elplanteo.com/?s=im+cannabis">M&aacute;s de IM Cannabis en Espa&ntilde;ol en El Planteo.</a>

Israel-Based IM Cannabis Continues Canadian Expansion With $67.6M MYM Nutraceuticals Acquisition

In a week where overall markets traded up, cannabis stocks were in the red, despite a series of big news, M&amp;A and financing announcements.

Special purpose acquisition company Mercer Park Brand Acquisition Corp. (NEO:BRND.A.U) (OTCQX:<a class="ticker" href="/stock/MRCQF#OTCQX">MRCQF</a>) will acquire vertically integrated California cannabis operator Glass House Group for $567 million.

The deal implies a $1.024-billion equity valuation and an approximate enterprise valuation of $691 million.

Curaleaf Holdings, Inc. (CSE:<a class="ticker" href="/stock/CURA#CSE">CURA</a>) (OTCQX:<a class="ticker" href="/stock/CURLF#OTCQX">CURLF</a>) purchased European operator EMMAC Life Sciences. The U.S.-based company agreed to pay $50 million in cash and 17.5 million in stock -- worth roughly $260 million.

In addition, Curaleaf teamed up with an institutional investor to secure $130 million in financing for further expansion of Curaleaf International.

Meanwhile, Canopy Growth Corporation (TSX:<a class="ticker" href="/stock/WEED#TSX">WEED</a>) (NASDAQ:<a class="ticker" href="/stock/CGC#NASDAQ">CGC</a>) announced it will buy The Supreme Cannabis Company, Inc. (TSX:<a class="ticker" href="/stock/FIRE#TSX">FIRE</a>) (OTCQX:<a class="ticker" href="/stock/SPRWF#OTCQX">SPRWF</a>) for about CA$435 million ($345.7 million).

The deal follows Canopy Growth&#39;s purchase last week of&nbsp;cannabis brand Ace Valley.&nbsp;

Benzinga Cannabis content is now available in Spanish on <a href="https://elplanteo.com/">El Planteo</a>. 

&ldquo;These cannabis deal numbers just keep getting bigger. Mercer Park is grabbing Glass House Group for over half a billion dollars, while Canopy Growth is picking up The Supreme Cannabis Company for $435 million. These numbers can&#39;t help but feel&nbsp;inflated. The revenues make the break-even so far into the future that one wonders if we are having another bubble,&rdquo; Debra Borchardt, editor-in-chief of Green Market Report, told Benzinga.

ETFs were all down. Over the five trading days of this week:

<ul>
	<li>The ETFMG Alternative Harvest ETF (NYSE:<a class="ticker" href="/stock/MJ#NYSE">MJ</a>): lost 2.6%.</li>
	<li>The AdvisorShares Pure Cannabis ETF (NYSE:<a class="ticker" href="/stock/YOLO#NYSE">YOLO</a>): tumbled 3.6%.</li>
	<li>The AdvisorShares Pure US Cannabis ETF (NYSE:<a class="ticker" href="/stock/MSOS#NYSE">MSOS</a>): dropped 1.5%.</li>
	<li>The Cannabis ETF (NYSE:<a class="ticker" href="/stock/THCX#NYSE">THCX</a>): slipped 1.55%.</li>
	<li>The Amplify Seymour Cannabis ETF (NYSE:<a class="ticker" href="/stock/CNBS#NYSE">CNBS</a>): dropped 2%.</li>
	<li>The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="/stock/SPY#NYSE">SPY</a>) was up 2.55%.</li>
</ul>

Trulieve Cannabis Corp. (CSE:<a class="ticker" href="/stock/TRUL#CSE">TRUL</a>) (OTC:<a class="ticker" href="/stock/TCNNF#OTC">TCNNF</a>) announced a marketed public offering of its shares. The company opted to sell 5 million subordinate voting shares in the United States and Canada in an underwritten public offering, at a price of C$50.00 per share (or $39.63 per share). Total proceeds before deductions, commissions and other expenses, are expected to come in at approximately $198.1 million.

<h2>Policy And Advocacy</h2>

Virginia became the first state in the South to legalize adult-use cannabis after the state&#39;s lawmakers approved several changes to cannabis bills SB 1406 and HB 2312, proposed by Virginia Governor Ralph Northam.

The two bills would create a statutory timeline for the legalization of the commercial cannabis market in the Old Dominion, and also enable the possession and growing of cannabis by adults. The personal use provisions of the law to take effect on July 1, 2021, instead of January 1, 2024, which was originally passed by lawmakers. &nbsp;

Illinois hit another record in marijuana sales, surpassing $100 million in March. According to the state Department of Financial and Professional Regulation, a total of 2,317,315 marijuana items worth $109,149,355 were sold over the period.

Texas lawmakers unanimously voted for a medical cannabis expansion bill in the Public Health House Committee. With the Committee&rsquo;s passage, the bill is now moved to the Calendars Committee to be scheduled for a vote by the House of Representatives.

The medical cannabis bill, HB 1535, sponsored by Chairwoman Stephanie Klick, proposes adding PTSD (for veterans only), cancer, and chronic pain to the list of health conditions that qualify patients for treatment with medical cannabis. Furthermore, the bill would increase the THC cap for medical cannabis products from 0.5% to 5%.

A new coalition dubbed The Cannabis Freedom Alliance was launched, backed by right-wing billionaire Charles Koch and criminal reform advocate Weldon Angelos, alongside:

<ul>
	<li>Americans for Prosperity: the political advocacy group founded by the Koch brothers);</li>
</ul>

<ul>
	<li>The Reason Foundation: a libertarian think tank;</li>
	<li>The Global Alliance for Cannabis Commerce: a cannabis trade organization;</li>
	<li>The Weldon Project: a nonprofit that fights for the release of those incarcerated for cannabis offenses.</li>
</ul>

<h2>Earnings Reports</h2>

Planet 13 Holdings Inc. (OTCQX:<a class="ticker" href="/stock/PLNHF#OTCQX">PLNHF</a>) reported it has generated $23.8 million in the first three months of 2021. March revenue amounted to $9.7 million, representing its single-month record.

Verano Holdings Corp. (CSE:<a class="ticker" href="/stock/VRNO#CSE">VRNO</a>) (OTCQX:<a class="ticker" href="/stock/VRNOF#OTCQX">VRNOF</a>) reported its revenue amounted to $355 million in fiscal 2020, representing a 196% year-over-year increase.

KushCo Holdings, Inc. (OTCQX:<a class="ticker" href="/stock/KSHB#OTCQX">KSHB</a>) generated $32.9 million in revenue in the second quarter, representing a 23% sequential increase, and 9% year-over-year growth.

Slang Worldwide Inc. (CSE:<a class="ticker" href="/stock/SLNG#CSE">SLNG</a>) (OTCQB:<a class="ticker" href="/stock/SLGWF#OTCQB">SLGWF</a>) released preliminary, unaudited full-year and fourth-quarter 2020 financial results with quarterly revenue of CA$9.66 million ($7.7 million), compared to CA$8.7 million in the same period of 2019.

Agrify Corporation (NASDAQ:<a class="ticker" href="/stock/AGFY#NASDAQ">AGFY</a>) announced Q4 and year-end financial results. Full-year 2020 revenue nearly tripled year-over-year to $12.1 million.

Find all the details on these and other earnings reports on <a href="https://www.benzinga.com/cannabis/earnings">Benzinga Cannabis&rsquo; Earnings Center</a>.

<h2>Financings And M&amp;A</h2>

IM Cannabis (CSE:<a class="ticker" href="/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>) continues to strategically expand in Canada with its second acquisition of 2021. This week it reached a definitive agreement to acquire MYM Nutraceuticals and its Licensed Producer subsidiary Highland Growth for C$85 million ($67.6 million).

Trulieve acquired three Pennsylvania-based medical marijuana dispensaries for $60 million in cash and stock.

InterCure LTd. (TASE: INCR), doing business as Canndoc, is poised to acquire medical cannabis brand Better Holdings for $35 million.

Fyllo raised $30 million&nbsp;via an oversubscribed Series B round co-led by JW Asset Management and Sol Global.

Organigram Holdings Inc. (TSX:<a class="ticker" href="/stock/OGI#TSX">OGI</a>) (NASDAQ:<a class="ticker" href="/stock/OGI#NASDAQ">OGI</a>) purchased The Edibles &amp; Infusions Corp. for $22 million.

Cansortium Inc. (CSE:<a class="ticker" href="/stock/TIUM#CSE">TIUM</a>) (OTCQB:<a class="ticker" href="/stock/CNTMF#OTCQB">CNTMF</a>) secured some $12 million in financing through a sale of roughly 17.14 million of its units at 70 cents per unit.

Akerna (NASDAQ:<a class="ticker" href="/stock/KERN#NASDAQ">KERN</a>) closed its acquisition of Viridian Sciences.

<h2>Other News</h2>

Orange County, New York&#39;s Industrial Development Agency approved local financial incentives for cannabis company Green Thumb Industries Inc (OTCQX:<a class="ticker" href="/stock/GTBIF#OTCQX">GTBIF</a>) (CSE:<a class="ticker" href="/stock/GTII#CSE">GTII</a>) to build a marijuana cultivation and manufacturing facility.

Green Thumb plans to buy the remaining eight lots, covering around 40 acres, at the Warwick Valley Office and Technology Corporate Park to construct a state-of-the-art cultivation and manufacturing facility.

Cronos Group (NASDAQ:<a class="ticker" href="/stock/CRON#NASDAQ">CRON</a>)-backed hemp and cannabis licensed producer NatuEra is exporting THC from Colombia to the United States. The shipment was imported by California&rsquo;s Biopharmaceutical Research Company and was approved by the U.S. DEA and Colombia&rsquo;s National Narcotics Control Board.

Stigma Grow and its parent company, CanadaBis Capital Inc. (TSXV:<a class="ticker" href="/stock/CANB#TSXV">CANB</a>) signed a third-party production agreement with Sundial Growers Inc&nbsp;(NASDAQ:&nbsp;SNDL) to manufacture several of&nbsp;Sundial&rsquo;s hydrocarbon concentrates.

Aleafia Health Inc. (TSX:<a class="ticker" href="/stock/AH#TSX">AH</a>) (OTCQX:<a class="ticker" href="/stock/ALEAF#OTCQX">ALEAF</a>) launched a new everyday cannabis brand, dubbed Divvy.

Subversive Acquisition LP (OTCQX:<a class="ticker" href="/stock/SBVRF#OTCQX">SBVRF</a>)(TSX:<a class="ticker" href="/stock/SVX#TSX">SVX</a>)(NEO: SVX.U) announced that InterCure, an Israel-based company it will be combining with this month, signed an agreement with Berner&rsquo;s famed cannabis brand Cookies for its European expansion.

Detroit-based Common Citizen and San Francisco-based Sherbinskis have launched a partnership for Common Citizen to grow Sherbinskis&rsquo; world-famous cannabis strains in Marshall, Michigan.

Fast-acting cannabis edibles brand Azuca announced a new partnership with Everest Apothecary to bring infused edible products to medical cannabis patients in New Mexico.

Azuca CEO Kim Rael told Benzinga, &ldquo;We are proud to work with Everest to bring Azuca&#39;s chef-quality edible products to the New Mexico market. With our patent-pending TiME INFUSION&trade; technology, we are able to deliver consistent, trustworthy and fast-acting edibles consumers can rely on. As adult use cannabis legalization in New Mexico looks imminent, we believe Everest is the perfect partner to allow us to continue our expansion and fulfill the demand for high-quality infused products.&rdquo;

Lil Wayne&rsquo;s cannabis and lifestyle brand, GKUA, inked a deal with The Torch at LA Memorial Coliseum to host all 4/20 events for years to come. There will also be a debut VIP Party and Performance, UPROAR at The Torch at LA Memorial Coliseum, on August 13th 2021 featuring Lil Wayne, Young Money and Friends.

Veriheal announced a $20,000 <a href="https://www.veriheal.com/scholarship/">Innovation in Cannabis</a> scholarship to fund students pursuing degrees in the cannabis industry to support upcoming talent and bring fresh perspectives to the field. The scholarship launched last year and has been doubled to offer 20 grants in the amount of $1,000 each to qualifying student applicants.

The Emerald Cup will honor hemp activist and Native American leader Winona LaDuke with the 2021 Willie Nelson Lifetime Achievement Award.&nbsp;LaDuke will be honored on this Sunday, April 11, 2021 at 4:20PM PDT during the virtual &ldquo;The Emerald Cup Awards Show&#39;&#39; broadcast &nbsp;live on Social Club TV.

<h2>Executive Moves</h2>

Find out all about the latest executive moves at:

<a href="https://www.benzinga.com/markets/cannabis/21/04/20555750/cannabis-movers-shakers-jmp-group-gti-curaleaf-conception-nurseries-myconic-amp-neon-ncr-22nd-ce" title="Cannabis Movers &amp; Shakers: JMP Group, GTI, Curaleaf, Conception Nurseries, Myconic, AMP, Neon, NCR, 22nd Century, cbdMD">JMP Group, GTI, Curaleaf, Conception Nurseries, Myconic, AMP, Neon, NCR, 22nd Century, cbdMD</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20488335/cannabis-movers-shakers-kiaro-holdings-team-hytiva-herv-edibles" title="Cannabis Movers &amp; Shakers: Kiaro Holdings, Team Hytiva, Hervé Edibles">Kiaro Holdings, Team Hytiva, Herv&eacute; Edibles</a>

<h3>Top Stories Of The Week</h3>

Check out the top stories on Benzinga Cannabis this week:

<a href="https://www.benzinga.com/markets/cannabis/21/04/20555664/3-pot-stocks-looking-to-bounce" title="3 Pot Stocks Looking To Bounce">3 Pot Stocks Looking To Bounce</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20525336/tilrays-stock-just-lost-a-key-level-but-there-may-still-be-hope" title="Tilray's Stock Just Lost A Key Level, But There May Still Be Hope">Tilray&#39;s Stock Just Lost A Key Level, But There May Still Be Hope</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20485289/ra-l-elizalde-on-the-benefits-of-cannabis-legalization-in-mexico-potentially-the-biggest-market-" title="Raúl Elizalde On The Benefits Of Cannabis Legalization In Mexico, Potentially The Biggest Market In The World">Ra&uacute;l Elizalde On The Benefits Of Cannabis Legalization In Mexico, Potentially The Biggest Market In The World</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20542709/china-may-soon-halt-cbd-cosmetics-trade-forcing-manufacturers-to-turn-to-exports" title="China May Soon Halt CBD Cosmetics Trade, Forcing Manufacturers To Turn To Exports">China May Soon Halt CBD Cosmetics Trade, Forcing Manufacturers To Turn To Exports</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20557930/want-to-study-cannabis-chemistry-you-may-even-get-the-scholarship" title="Want To Study Cannabis Chemistry? You May Even Get The Scholarship">Want To Study Cannabis Chemistry? You May Even Get The Scholarship</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20545576/cannabis-dispensary-openings-trulieve-ayr-high-tide-cookies-medmen-curaleaf-inner-spirit-c3-indu" title="Cannabis Dispensary Openings: Trulieve, Ayr, High Tide, Cookies, MedMen, Curaleaf, Inner Spirit, C3 Industries">Cannabis Dispensary Openings: Trulieve, Ayr, High Tide, Cookies, MedMen, Curaleaf, Inner Spirit, C3 Industries</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20546553/could-psychedelic-medicines-have-helped-prevent-dmxs-overdose" title="Could Psychedelic Medicines Have Helped Prevent DMX's Overdose?">Could Psychedelic Medicines Have Helped Prevent DMX&#39;s Overdose?</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20460435/video-women-execs-in-the-cannabis-industry-address-challenges-opportunities-and-more" title="Video: Women Execs In The Cannabis Industry Address Challenges, Opportunities And More">Video: Women Execs In The Cannabis Industry Address Challenges, Opportunities And More</a>

<a href="https://www.benzinga.com/markets/cannabis/21/04/20467737/mexicos-cannabis-legalization-and-the-potential-boom-of-wellness-travel-what-it-means-for-invest" title="Mexico's Cannabis Legalization And The Potential Boom Of Wellness Travel: What It Means For Investors">Mexico&#39;s Cannabis Legalization And The Potential Boom Of Wellness Travel: What It Means For Investors</a>

Top Spanish stories:

<ul>
	<li><a href="https://elplanteo.com/por-que-invertir-en-psicodelicos/">&iquest;Por Qu&eacute; Invertir en Psicod&eacute;licos?</a></li>
	<li><a href="https://elplanteo.com/raul-elizalde-ceo-de-hempmeds-habla-sobre-los-beneficios-de-la-legalizacion-del-cannabis-en-mexico/">Ra&uacute;l Elizalde, CEO de HempMeds, Habla sobre los Beneficios de la Legalizaci&oacute;n del Cannabis en M&eacute;xico</a></li>
	<li><a href="https://elplanteo.com/quieren-porro-flashea-con-las-adidas-edicion-especial-de-south-park-para-el-420/">&lsquo;&iquest;Quieren Porro?&rsquo;: Flashe&aacute; con las Adidas Edici&oacute;n Especial de South Park para el 420</a></li>
	<li><a href="https://elplanteo.com/cannabis-solidario-la-historia-del-banco-cannabico-argentino/">Cannabis Solidario: la Historia del Banco Cann&aacute;bico Argentino</a></li>
	<li><a href="https://elplanteo.com/las-confesiones-de-stuart-musica-melodica-fms-cannabis-y-freestyle/">Las Confesiones de Stuart: M&uacute;sica Mel&oacute;dica, FMS, Cannabis y Freestyle</a></li>
	<li><a href="https://elplanteo.com/activismo-afrodescendencia-y-hip-hop-con-luyara-tink-el-movimiento-se-fue-tergiversando/">Activismo, Afrodescendencia y Hip Hop con Luyara Tink: &lsquo;El Movimiento se Fue Tergiversando&rsquo;</a></li>
	<li><a href="https://elplanteo.com/mexico-que-implican-para-inversores-la-legalizacion-del-cannabis-y-el-potencial-turismo-de-wellness/">M&eacute;xico: Qu&eacute; Implican para Inversores la Legalizaci&oacute;n del Cannabis y el Potencial Turismo de &lsquo;Wellness&rsquo;</a></li>
	<li><a href="https://elplanteo.com/cooperativa-cannabica-ananda-una-alternativa-para-el-desarrollo-local-y-sustentable-cannabis-ecuador/">Cooperativa Cann&aacute;bica ANANDA: una Alternativa para el Desarrollo Local y Sustentable</a></li>
	<li><a href="https://elplanteo.com/como-invertir-dinero/">C&oacute;mo Invertir Dinero en el Mercado Accionario desde Latinoam&eacute;rica</a></li>
	<li><a href="https://elplanteo.com/que-es-weed-que-significa-en-espanol/">&iquest;Qu&eacute; es &lsquo;Weed&rsquo;? &iquest;Qu&eacute; Significa en Espa&ntilde;ol?</a></li>
	<li><a href="https://elplanteo.com/detective-cannabico-de-los-cultivos-solidarios-al-activismo-recreativo/">Detective Cann&aacute;bico: de los Cultivos Solidarios al Activismo Recreativo</a></li>
	<li><a href="https://elplanteo.com/muerte-por-marihuana-mito-o-realidad/">Muerte por Marihuana: &iquest;Mito o Realidad?</a></li>
</ul>

Lead image by <a href="https://www.behance.net/ilona-szentivanyi">Ilona Szentivanyi</a>. Copyright: Benzinga.

After-Hours Center

The Week In Cannabis: Glass House, Canopy, Curaleaf, Trulieve, Virginia And More

Multi-country medical and recreational cannabis operator IM Cannabis (CSE:<a class="ticker" href="/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>) is gearing up to expand its product offering in the German market this year with a range of specially formulated high-THC, balanced-THC and CBD oil extracts.

The company announced its German subsidiary, Adjupharm GmbH, signed a two-year supply agreement with MediPharm Labs (OTC:<a class="ticker" href="/stock/MEDIF#OTC">MEDIF</a>) for the production and delivery of IMC-branded, specially formulated extracts. The products will be distributed by Adjupharm and its network to more than 6,000 pharmacies across Germany.&nbsp;

&ldquo;The agreement with MediPharm is part of our multipronged approach to growing IMC&rsquo;s business in key international markets not only through M&amp;As,&quot; Oren Shuster, CEO of IMC, told Benzinga, &quot;but also by the leveraging strong business relationships to enable the introduction and expansion of premium product portfolio to cater to the needs of patients and physicians. As demand for premium medical cannabis extracts grows in Germany, it provides an excellent opportunity for IMC to deploy this strategy.&rdquo;

The agreement with MediPharm Labs comes on the heels of another supply agreement IMC announced earlier this week with Canadian-based Northern Green Canada to supply IMC-branded medical cannabis to the German market as well.

Photo by <a href="https://unsplash.com/@christianw?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Christian Wiediger</a> on <a href="https://unsplash.com/s/photos/germany?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

IM Cannabis, MediPharm Labs Sign Supply Agreement For German Market

Benzinga&rsquo;s&nbsp;<a href="https://www.youtube.com/playlist?list=PL4k0fH8EgI3ZSvns1pymdSRwOIA-exAaA" rel="noopener noreferrer" target="_blank">Cannabis Insider</a>&nbsp;is a live daily show for cannabis investors. 
Hosts Patrick&nbsp;Lane and&nbsp;<a href="https://elplanteo.com/author/javier-hasse/" rel="noopener noreferrer" target="_blank">Javier Hasse</a>&nbsp;discussed recent news in the Cannabis Industry and Trading for Cannabis Investors.

Lane and Hasse also had time to look into the following publicly-traded companies:&nbsp;

<ul>
	<li>Tilt Holdings Inc (OTC:<a class="ticker" href="/stock/TLLTF#OTC">TLLTF</a>)</li>
	<li>The Valens Co Inc (OTC:<a class="ticker" href="/stock/VLNCF#OTC">VLNCF</a>)</li>
	<li>Ayr Wellness Inc (OTC:<a class="ticker" href="/stock/AYRWF#OTC">AYRWF</a>)</li>
	<li>Trulieve Cannabis Corp (OTC:<a class="ticker" href="/stock/TCNNF#OTC">TCNNF</a>)</li>
	<li>Cresco Labs (OTC:<a class="ticker" href="/stock/CRLBF#OTC">CRLBF</a>)</li>
	<li>Green Thumb Industries (OTC:<a class="ticker" href="/stock/GTBIF#OTC">GTBIF</a>)</li>
	<li>Urgan-Gro Inc (NASDAQ:<a class="ticker" href="/stock/UGRO#NASDAQ">UGRO</a>)</li>
	<li>IM Cannabis Corp (NASDAQ:<a class="ticker" href="/stock/IMCC#NASDAQ">IMCC</a>)</li>
	<li>Columbia Care Inc (OTC:<a class="ticker" href="/stock/CCHWF#OTC">CCHWF</a>)</li>
</ul>

<iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" frameborder="0" height="315" src="https://www.youtube.com/embed/z9woeekiz20" width="560"></iframe>

The cannabis industry is a wealth of trading opportunities, its growth is driven by legalization that continues to spread across the US and Canada and spurred on by ever-increasing support from the public. Benzinga&rsquo;s Cannabis Insider is a live daily show for cannabis investors in day trading. Subscribe for daily trade ideas <a dir="auto" href="https://www.youtube.com/c/Benzinga%E2%80%8B%E2%80%8B%E2%80%8B" rel="nofollow">https://www.youtube.com/c/Benzinga​​​</a>​

There are a few unique advantages that CFDs offer over traditional investment and have reasons to believe that the cannabis industry&#39;s prospects for continued growth look good. Your key payment for trading cannabis is the spread for executing your trade. We work to keep our spreads among the lowest in the business.

A cannabis trading is a gauge of performance from a section of the cannabis industry. The price of cannabis trading will be derived from the prices of a selection of related cannabis assets. These could be the 20 top-performing cannabis stocks.

We&rsquo;re likely to see some significant changes to the cannabis industry. The cannabis market is expected to grow, but customers are likely to be more educated about cannabis and purchase different types of cannabis products. There are many challenges the cannabis industry will face.

The compound annual growth rate of the marijuana industry has been estimated at around 21%. A majority of doctors support medical marijuana at 76%. There has been a 140% increase in the number of people who used cannabis for the first time.

Disclaimer: All of the information, material, and/or content contained in this program is for informational purposes only. Investing in stocks, options, and futures is risky and not suitable for all investors. Please consult your own independent financial adviser before making any investment decisions.Cannabis Insider, Benzinga Cannabis Insider, Cannabis Stocks YouTube, Cannabis Stocks Show,

Video: Benzinga Cannabis Insider Ft. Cresco Labs, Tilt, Trulieve And More

The Week In Cannabis: PA, MD, Big Tobacco, GTI, Sundial, MedMen, Earnings, Financings And More

<h3>Gainers</h3>

<ul>
	<li>Nemaura Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) shares jumped 64.9% to $7.75 after the company reported an order for 200,000 sugarBEAT sensors.</li>
	<li>Chiasma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHMA#NASDAQ">CHMA</a>) gained 53.5% to $4.36 after Amryt Pharma agreed to acquire the company in an all-stock combination.</li>
	<li>iBio, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NYSE">IBIO</a>) jumped 47.3% to $1.90 after the company announced it successfully resolved its lawsuit with Fraunhofer USA.</li>
	<li>Athenex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNX#NASDAQ">ATNX</a>) shares climbed 43% to $5.30 after the company reported its acquired Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) gained 40.4% to $13.94.</li>
	<li>Hayward Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NASDAQ">HAYW</a>) jumped 23.6% to $23.97 after the company reported better-than-expected Q1 sales.</li>
	<li>Superior Industries International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUP#NYSE">SUP</a>) gained 20.6% to $6.19 following Q1 results.</li>
	<li>Big 5 Sporting Goods Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) surged 20% to $22.89 after the company reported better-than-expected Q1 results and also issued strong Q2 EPS guidance.</li>
	<li>Ault Global Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPW#NYSE">DPW</a>) gained 17.3% to $3.11 after the company reported it sees preliminary Q1 sales of $13 million, up 132% year over year.</li>
	<li>DAVIDsTEA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTEA#NASDAQ">DTEA</a>) shares jumped 16.5% to $3.75 after the company announced it will seek court authorization for Companies&#39; Creditors Arrangement Act.</li>
	<li>Rocky Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) surged 15.7% to $62.35 after reporting a rise in quarterly earnings.</li>
	<li>KAR Auction Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAR#NYSE">KAR</a>) shares rose 15.7% to $16.79 following upbeat quarterly results.</li>
	<li>Caesarstone Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTE#NASDAQ">CSTE</a>) gained 15% to $16.59 following strong quarterly results.</li>
	<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) gained 15% to $258.70 after the company reported better-than-expected Q1 results and issued strong FY21 EPS and sales guidance.</li>
	<li>Clovis Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVS#NASDAQ">CLVS</a>) jumped 14.2% to $6.29 after the company posted a narrower-than-expected quarterly loss.</li>
	<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) gained 13.8% to $13.40. B of A Securities upgraded Oceaneering International from Neutral to Buy and raised the price target from $12.5 to $15.</li>
	<li>American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) rose 13.2% to $3.08 after dropping over 27% on Tuesday.</li>
	<li>Navios Maritime Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NM#NYSE">NM</a>) gained 13.2% to $10.27.</li>
	<li>XP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) climbed 13.1% to $43.47 after the company reported Q1 net income and total gross sales results up from last year.</li>
	<li>MRC Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) surged 12.5% to $10.86.</li>
	<li>Fresh Del Monte Produce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) gained 12.3% to $32.44 following strong quarterly earnings.</li>
	<li>Belden Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) surged 10.7% to $47.71 after the company reported better-than-expected Q1 results and raised FY21 sales guidance.</li>
	<li>Nabors Industries Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBR#NYSE">NBR</a>) gained 9.3% to $88.62.</li>
	<li>NOW Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNOW#NYSE">DNOW</a>) gained 8.8% to $11.08 after the company reported better-than-expected Q1 results.</li>
	<li>Caesars Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) rose 6.5% to $101.77 after the company reported Q1 earnings results.</li>
	<li>Alteryx, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AYX#NYSE">AYX</a>) shares rose 6.3% to $81.17 after the company reported better-than-expected Q1 results.</li>
	<li>Match Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTCH#NASDAQ">MTCH</a>) rose 5% to $145.12 after the company reported better-than-expected Q1 sales and issued strong Q2 sales guidance.</li>
	<li>Activision Blizzard, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATVI#NASDAQ">ATVI</a>) rose 4.2% to $92.36 after the company reported Q1 earnings results and issued Q2 guidance.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Cocrystal Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCP#NASDAQ">COCP</a>) shares fell 32.2% to $1.45 after the company announced a $40 million bought deal offering of common stock.</li>
	<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) fell 28.6% to $10.28 after the company reported worse-than-expected Q1 results. B. Riley FBR downgraded Intrusion from Buy to Neutral and lowered the price target from $30 to $13.5.</li>
	<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) shares dropped 26.7% to $18.77 after the company reported worse-than-expected Q1 results. Stifel downgraded Esperion Therapeutics from Buy to Hold and lowered the price target from $37 to $20.</li>
	<li>Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) fell 19.8% to $56.28 after reporting Q3 results.</li>
	<li>Adamis Pharmaceuticals Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) fell 19.4% to $0.8620 after surging 40% on Tuesday.</li>
	<li>Rayonier Advanced Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NASDAQ">RYAM</a>) dropped 19.1% to $7.37 after reporting a loss for its first quarter.</li>
	<li>Bottomline Technologies (de), Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPAY#NASDAQ">EPAY</a>) dipped 16.6% to $38.62 after the company reported worse-than-expected Q3 sales results. Craig-Hallum downgraded Bottomline Technologies from Buy to Hold.</li>
	<li>Precipio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PRPO#NASDAQ">PRPO</a>) shares fell 16% to $4.41. Recently, the company successfully launched its COVID-19 rapid antibody test that tests for both IgG &amp; IgM antibodies.</li>
	<li>Astec Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTE#NASDAQ">ASTE</a>) dropped 16% to $64.46 following downbeat quarterly results.</li>
	<li>IM Cannabis Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) fell 15.1% to $5.45 after the company reported pricing of proposed public offering of securities.</li>
	<li>Kimball International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBAL#NASDAQ">KBAL</a>) dropped 14.4% to $12.47 following weak quarterly results.</li>
	<li>Lumber Liquidators Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LL#NYSE">LL</a>) fell 14.35% to $21.22 following downbeat quarterly sales.</li>
	<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) fell 14% to $4.2006. BioLineRx shares climbed 53% on Tuesday after the company announced positive top-line results from the GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, in combination with granulocyte colony stimulating factor, the standard-of-care, for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.</li>
	<li>Systemax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYX#NYSE">SYX</a>) dropped 14% to $36.71 after the company posted downbeat quarterly results.</li>
	<li>FedNat Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNHC#NASDAQ">FNHC</a>) fell 13.4% to $4.45 following weak quarterly results.</li>
	<li>Upwork Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UPWK#NASDAQ">UPWK</a>) dropped 12% to $37.78 after the company reported Q1 earnings results.</li>
	<li>Cardlytics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) fell 10.3% to $115.02 after reporting a Q1 loss.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) fell 10.3% to $5.33 after jumping 58% on Tuesday.</li>
	<li>CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) dipped 9.5% to $122.15 after the company issued mixed Q2 guidance.</li>
	<li>Dolby Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) fell 9% to $94.22 after the company issued Q3 EPS guidance below analyst estimates. The company also said Lewis Chew, Executive Vice President and Chief Financial Officer has decided to retire later this year.</li>
	<li>HollyFrontier Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HFC#NYSE">HFC</a>) fell 8.1% to $33.27 after the company reported a Q1 loss and announced the acquisition of Puget Sound Refinery for $350 million.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) fell 6% to $51.96. Last week, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.</li>
</ul>

Intraday Update

Movers

Trading Ideas

50 Stocks Moving In Wednesday's Mid-Day Session

<h3>Gainers</h3>

<ul>
	<li>Nemaura Medical Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NMRD#NASDAQ">NMRD</a>) shares surged 135.3% to close at $11.06 on Wednesday after the company receipt of a purchase order for 5,000 sugarBEAT transmitters and 200,000 sugarBEAT sensors from its U.K. licensee, DB Ethitronix Ltd.</li>
	<li>Regional Health Properties, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RHE#NYSE">RHE</a>) jumped 96.3% to close at $19.49.</li>
	<li>The Honest Company, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HNST#NASDAQ">HNST</a>) shares climbed 43.8% to settle at $23.00 after the company priced its IPO at $16 per share.</li>
	<li>Chiasma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHMA#NASDAQ">CHMA</a>) rose 40.1% to settle at $3.98 after Amryt Pharma agreed to acquire the company in an all-stock combination.</li>
	<li>Big 5 Sporting Goods Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BGFV#NASDAQ">BGFV</a>) jumped 31.2% to settle at $25.01 after the company reported better-than-expected Q1 results and also issued strong Q2 EPS guidance.</li>
	<li>American Shared Hospital Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMS#NYSE">AMS</a>) jumped 30.5% to close at $3.55 after dropping over 27% on Tuesday.</li>
	<li>SunLink Health Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SSY#NYSE">SSY</a>) gained 29.8% to close at $3.70.</li>
	<li>Ever-Glory International Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVK#NYSE">EVK</a>) rose 29.2% to settle at $3.05.</li>
	<li>KBS Fashion Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBSF#NASDAQ">KBSF</a>) gained 25.9% to close at $3.55.</li>
	<li>Hayward Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HAYW#NASDAQ">HAYW</a>) gained 24.3% to settle at $24.11 after the company reported better-than-expected Q1 sales.</li>
	<li>InnSuites Hospitality Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IHT#NYSE">IHT</a>) rose 24.3% to close at $2.56.</li>
	<li>Alfi, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALF#NASDAQ">ALF</a>) gained 23.5% to settle at $3.58. Alfi recently reported pricing of $15.5 million initial public offering and Nasdaq listing.</li>
	<li>Altisource Portfolio Solutions S.A. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASPS#NASDAQ">ASPS</a>) surged 23.3% to close at $7.21.</li>
	<li>Athenex, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNX#NASDAQ">ATNX</a>) shares jumped 22.6% to settle at $4.55 after the company reported its acquired Kuur Therapeutics Inc, a portfolio company of IP Group plc, for $70 million upfront.</li>
	<li>Superior Industries International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUP#NYSE">SUP</a>) rose 22.1% to close at $6.26 following Q1 results.</li>
	<li>Five Star Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FSBC#NASDAQ">FSBC</a>) gained 21.3% to settle at $24.25 after pricing its IPO at $20 a share.</li>
	<li>Fresh Del Monte Produce Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDP#NYSE">FDP</a>) jumped 20% to close at $34.63 following strong quarterly earnings.</li>
	<li>Interlink Electronics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LINK#NASDAQ">LINK</a>) gained 19.8% to close at $13.78.</li>
	<li>Aziyo Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZYO#NASDAQ">AZYO</a>) surged 18.4% to close at $11.26 after the company reported better-than-expected Q1 results.</li>
	<li>KLX Energy Services Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KLXE#NASDAQ">KLXE</a>) gained 18.4% to settle at $10.56.</li>
	<li>Oceaneering International, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OII#NYSE">OII</a>) climbed 18.2% to settle at $13.91. B of A Securities upgraded Oceaneering International from Neutral to Buy and raised the price target from $12.5 to $15.</li>
	<li>DAVIDsTEA Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DTEA#NASDAQ">DTEA</a>) shares surged 18% to settle at $3.80 after the company announced it will seek court authorization for Companies&#39; Creditors Arrangement Act.</li>
	<li>Rocky Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCKY#NASDAQ">RCKY</a>) climbed 16.2% to close at $62.50 after reporting a rise in quarterly earnings.</li>
	<li>KAR Auction Services, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KAR#NYSE">KAR</a>) shares surged 16% to settle at $16.83 following upbeat quarterly results.</li>
	<li>iBio, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IBIO#NYSE">IBIO</a>) gained 14.7% to close at $1.48 after the company announced it successfully resolved its lawsuit with Fraunhofer USA.</li>
	<li>Universal Security Instruments, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UUU#NYSE">UUU</a>) gained 14.3% to close at $6.46 on above-average volume.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) surged 14.2% to settle at $4.74 amid strength in coal names.</li>
	<li>MRC Global Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRC#NYSE">MRC</a>) jumped 14.1% to settle at $11.01.</li>
	<li>Medifast, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MED#NYSE">MED</a>) rose 12.1% to close at $252.28 after the company reported better-than-expected Q1 results and issued strong FY21 EPS and sales guidance.</li>
	<li>Belden Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDC#NYSE">BDC</a>) surged 11.9% to close at $48.22 after the company reported better-than-expected Q1 results and raised FY21 sales guidance.</li>
	<li>XP Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XP#NASDAQ">XP</a>) surged 11.3% to close at $42.77 after the company reported Q1 net income and total gross sales results up from last year.</li>
	<li>Caesarstone Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSTE#NASDAQ">CSTE</a>) rose 10.6% to close at $15.95 following strong quarterly results.</li>
	<li>Nabors Industries Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NBR#NYSE">NBR</a>) rose 10.2% to close at $89.30.</li>
	<li>Express, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EXPR#NYSE">EXPR</a>) gained 10.1% to settle at $3.49.</li>
	<li>Navios Maritime Holdings Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NM#NYSE">NM</a>) rose 8.1% to close at $9.80.</li>
	<li>Caesars Entertainment, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) gained 7.8% to close at $102.98 after the company reported Q1 earnings results.</li>
	<li>NOW Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DNOW#NYSE">DNOW</a>) gained 7.2% to settle at $10.91 after the company reported better-than-expected Q1 results.</li>
	<li>Ault Global Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DPW#NYSE">DPW</a>) rose 6.4% to close at $2.82 after the company reported it sees preliminary Q1 sales of $13 million, up 132% year over year.</li>
	<li>Clovis Oncology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLVS#NASDAQ">CLVS</a>) gained 6.4% to close at $5.86 after the company posted a narrower-than-expected quarterly loss.</li>
</ul>

&nbsp;

&nbsp;

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Cocrystal Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COCP#NASDAQ">COCP</a>) shares dipped 31.3% to close at $1.47 on Wednesday after the company announced a $40 million bought deal offering of common stock.</li>
	<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) fell 28.8% to close at $10.25 after the company reported worse-than-expected Q1 results. B. Riley FBR downgraded Intrusion from Buy to Neutral and lowered the price target from $30 to $13.5.</li>
	<li>Sequential Brands Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SQBG#NASDAQ">SQBG</a>) fell 27.1% to close at $12.40, potentially on continued weakness after the stock fell on Tuesday following the resignation of the company&#39;s chairman.</li>
	<li>Adamis Pharmaceuticals Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMP#NASDAQ">ADMP</a>) dipped 23.4% to settle at $0.8202 after surging 40% on Tuesday.</li>
	<li>Rayonier Advanced Materials Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYAM#NASDAQ">RYAM</a>) dropped 23.3% to close at $6.99 after reporting a loss for its first quarter.</li>
	<li>BioLineRx Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLRX#NASDAQ">BLRX</a>) fell 23.3% to close at $3.75. BioLineRx shares climbed 53% on Tuesday after the company announced positive top-line results from the GENESIS Phase 3 trial evaluating its lead clinical candidate, Motixafortide, in combination with granulocyte colony stimulating factor, the standard-of-care, for hematopoietic stem-cell mobilization for autologous bone marrow transplantation in multiple myeloma patients.</li>
	<li>Brooklyn ImmunoTherapeutics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTX#NYSE">BTX</a>) fell 21.9% to settle at $43.09. Last week, Brooklyn ImmunoTherapeutics filed a Form 8-K showing that it entered into a purchase agreement with Lincoln Park Capital on Apr. 26 in which the company can sell up to $20 million of common shares to the Chicago-based investment group and asset management firm. Additionally, Nicholas J Singer disclosed that he took a 9%-plus stake in the company in a 13G filing on Friday.</li>
	<li>Esperion Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESPR#NASDAQ">ESPR</a>) shares dipped 21.8% to close at $20.01 after the company reported worse-than-expected Q1 results. Stifel downgraded Esperion Therapeutics from Buy to Hold and lowered the price target from $37 to $20.</li>
	<li>Systemax Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SYX#NYSE">SYX</a>) dropped 21.8% to close at $33.38 after the company posted downbeat quarterly results.</li>
	<li>Team, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TISI#NYSE">TISI</a>) fell 18.5% to settle at $8.57 after the company late Tuesday reported worse-than-expected Q1 results.</li>
	<li>Mercury Systems, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRCY#NASDAQ">MRCY</a>) fell 17.8% to close at $57.69 after reporting Q3 results.</li>
	<li>PDS Biotechnology Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PDSB#NASDAQ">PDSB</a>) dipped 17.6% to close at $4.96.</li>
	<li>Cardlytics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDLX#NASDAQ">CDLX</a>) fell 17% to close at $106.34 after reporting a Q1 loss.</li>
	<li>Bottomline Technologies (de), Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EPAY#NASDAQ">EPAY</a>) dipped 16.8% to close at $38.55 after the company reported worse-than-expected Q3 sales results. Craig-Hallum downgraded Bottomline Technologies from Buy to Hold.</li>
	<li>Vaxart, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VXRT#NASDAQ">VXRT</a>) fell 15.8% to close at $7.38, potentially amid profit taking after the stock gained on Tuesday following oral COVID-19 data.</li>
	<li>FedNat Holding Company (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FNHC#NASDAQ">FNHC</a>) fell 15.4% to close at $4.35 following weak quarterly results.</li>
	<li>IM Cannabis Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) fell 15.4% to close at $5.43 after the company reported pricing of proposed public offering of securities.</li>
	<li>MoSys, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOSY#NASDAQ">MOSY</a>) dipped 15.3% to settle at $3.81.</li>
	<li>Intellicheck, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IDN#NYSE">IDN</a>) fell 15.2% to close at $8.14 after the company reported worse-than-expected Q1 EPS and sales results.</li>
	<li>Kimball International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KBAL#NASDAQ">KBAL</a>) dropped 15% to close at $12.37 following weak quarterly results.</li>
	<li>Silk Road Medical, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SILK#NASDAQ">SILK</a>) fell 14.8% to settle at $52.33 after the company reported Q1 earnings results.</li>
	<li>Alector, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALEC#NASDAQ">ALEC</a>) fell 14.7% to close at $15.71.</li>
	<li>Peloton Interactive, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTON#NASDAQ">PTON</a>) dipped 14.6% to close at $82.62.</li>
	<li>Deciphera Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DCPH#NASDAQ">DCPH</a>) fell 14.5% to settle at $37.02 after the company reported Q1 earnings results. Following earnings, HC Wainwright &amp; Co lowered its price target on the stock from $80 to $75.</li>
	<li>Astec Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTE#NASDAQ">ASTE</a>) dropped 14.4% to close at $65.95 following downbeat quarterly results.</li>
	<li>Myriad Genetics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>) fell 13% to close at $27.51.</li>
	<li>Sana Biotechnology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SANA#NASDAQ">SANA</a>) dropped 13% to settle at $16.67.</li>
	<li>CyberArk Software Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>) dipped 11.7% to settle at $119.17 after the company issued mixed Q2 guidance.</li>
	<li>SemiLEDs Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LEDS#NASDAQ">LEDS</a>) fell 7.4% to close at $5.50 after jumping 58% on Tuesday.</li>
	<li>Lumber Liquidators Holdings, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LL#NYSE">LL</a>) fell 6.7% to close at $23.09 following downbeat quarterly sales.</li>
	<li>Dolby Laboratories, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLB#NYSE">DLB</a>) fell 6.3% to close at $96.98 after the company issued Q3 EPS guidance below analyst estimates. The company also said Lewis Chew, Executive Vice President and Chief Financial Officer has decided to retire later this year.</li>
</ul>

Pre-Market Outlook

70 Biggest Movers From Yesterday

MediPharm Labs Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LABS#TSX">LABS</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTCQX">MEDIF</a>) (FSE:MLZ) reported Monday its first-quarter revenue amounted to CA$5.49 million ($4.53 million), down by roughly 9% sequentially and 50% year-over-year.

Adjusted EBITDA, a non-IFRS measure, came in negative at roughly CA$6.16 million, representing an improvement from a CA$8.77 million loss in the prior quarter and a loss of CA$5.66 million in the same quarter of 2020.

Greg Hunter, CFO of the Barrie, Ontario-based company, called the quarter a &quot;cross-over period to our future state as the preferred global cannabis API provider to medical and wellness markets.&quot;

<h3>Q1 2021 Highlights</h3>

<ul>
	<li>Gross profit was negative at CA$680 000 compared to a negative gross profit of CA$24.7 million in the previous quarter and CA$10.9 million in the same period of 2020.</li>
	<li>A negative gross margin was 12%, compared to a negative gross margin of 408% in the last three months of 2020 and 98% in the prior year&#39;s corresponding quarter.</li>
	<li>Net loss amounted to approximately CA$13.9 million, after shrinking by 55% sequentially and 37% year-over-year.</li>
	<li>International sales rose to CA$1.8 million over the last three months of 2020, to CA$2.1 million in the first quarter of 2021.</li>
	<li>The company achieved more than CA$1.5 million in cost savings.</li>
	<li>As of March 31, the company had CA$42.1 million in cash and cash equivalents.</li>
</ul>

&quot;We commenced 2021 focused on establishing our presence as a pharmaceutical company while ramping up and significantly growing our international sales,&quot; Hunter added.

In October, MediPharm Labs <a href="https://www.benzinga.com/markets/cannabis/20/10/17791321/medipharm-labs-inks-exclusive-supply-agreement-with-germanys-stada">inked a deal</a> to supply GMP-certified medical cannabis products to German pharmaceutical giant Stada Arzneimittel AG.

Six months later, in April, the company expanded its reach in the German market by signing a two-year supply agreement with the subsidiary of the multi-country medical and recreational cannabis operator IM Cannabis (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>), which agreed to expand its product offering in Germany in 2021.

Photo by <a href="https://unsplash.com/@diyahna22?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Diyahna Lewis</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

Earnings

MediPharm Posts Q1 2021 Results: What Cannabis Stock Investors Need To Know

The Flowr Corporation (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/FLWPF#OTCQX">FLWPF</a>) will&nbsp;export up to 500 kilos&nbsp;of premium dry cannabis flower in bulk into Israel.

The move follows the company&#39;s recent announcement that it had&nbsp;raised $15.9 million by selling units.

Deal Details: Under the terms of the&nbsp;supply agreement with Focus Medical Herbs Ltd.,&nbsp;a company with which IM Cannabis Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#CSE">IMCC</a>) has an exclusive commercial agreement within Israel, Flowr&#39;s wholly-owned subsidiary will&nbsp;export medical cannabis into the Middle Eastern country.

The Toronto-based company said Monday that it expects the first shipment of BC Pink Kush to hit the Israeli market in the second half of this year.

Flowr confirmed Monday that the collaboration with Focus Medical will last three years.

Darryl Brooker, CEO of Flowr, said he is delighter to team up with IMC and Focus Medical to introduce the company&#39;s product to the Israeli market.

&quot;Coupled with our ability to grow high THC premium dry flower from our EU GMP facilities in Portugal, we view this partnership as an important next step to becoming a significant international producer of cannabis with a globally recognized brand,&quot; Brooker continued.

Oren Shuster, CEO of IMC, looks forward to working with the Flowr team.&nbsp;

&quot;We believe that the Israeli market will receive Flowr&#39;s renowned BC&nbsp;Pink Kush and BC Black Cherry strains with open arms,&quot; Shuster added.

IMC&#39;s Recent Moves: IMC <a href="https://www.benzinga.com/markets/cannabis/20/10/17855574/im-cannabis-to-debut-on-nasdaq">debuted</a> on the NASDAQ Capital Market last year.

In April, the company confirmed the <a href="https://www.benzinga.com/markets/cannabis/21/04/20544376/israel-based-im-cannabis-continues-canadian-expansion-with-67-6m-mym-nutraceuticals-acquisition">acquisition</a> of MYM Nutraceuticals and its Licensed Producer subsidiary Highland Growth, which is scheduled&nbsp;to close by the end of 2021.

The recreational cannabis operator <a href="https://www.benzinga.com/markets/cannabis/21/04/20646293/im-cannabis-medipharm-labs-sign-supply-agreement-for-german-market">opted</a> to expand its product offering in the German market by launching a range of specially formulated high-THC, balanced-THC&nbsp;and CBD oil extracts as part of a two-year supply agreement between its German subsidiary Adjupharm GmbH and MediPharm Labs (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTC">MEDIF</a>).

Photo by <a href="https://unsplash.com/@elsaolofsson?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Elsa Olofsson</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

The Flowr Corp. To Export Up To 500KG Of Medical Cannabis To Israel

Trichome JWC Acquisition (TJAC), the Canadian subsidiary of multi-country operator IM Cannabis (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>), announced last week the launch of WAGNERS, a new adult-use cannabis brand in the premium segment of the market.

The announcement also marks the first foray of IM Cannabis, which focuses on the global medical cannabis sector, into the recreational cannabis market.

WAGNERS products, including new dried flower strains, pre-rolls and solventless concentrates (<a href="https://elplanteo.com/como-hacer-hachis-o-hash-instrucciones-paso-a-paso/">hash</a> and <a href="https://elplanteo.com/que-es-el-kief-como-extraerlo-y-como-usarlo/">kief</a>), are expected to hit the shelves in British Columbia and Ontario by mid-June and are currently available in multiple provinces across Canada including PEI, New Brunswick, Saskatchewan&nbsp;and Alberta.

Ross Hendry, head of sales and marketing with TJAC, told Benzinga that &ldquo;the WAGNERS brand is truly a reflection of our people, the shared values of our organization and the surrounding Tri-Cities community; hard work, dedication and perseverance. The launch of the brand across Canada is an exciting moment for TJAC and the IM Cannabis family as the first significant step in its Canadian market expansion.&rdquo;

To keep up with the expected demand for its WAGNERS product line, TJAC has ramped up cultivation and processing operations in its Kitchener, Ontario facility including quadrupling harvesting volumes.

Encuentra nuestro contenido en Espa&ntilde;ol en El Planteo:

<ul>
	<li><a href="https://elplanteo.com/que-es-un-blunt-te-ensenamos-a-armar-un-porro-con-hojas-de-tabaco/">&iquest;Qu&eacute; Es un Blunt? Te Ense&ntilde;amos a Armar un Porro con Hojas de Tabaco</a></li>
	<li><a href="https://elplanteo.com/cuantos-gramos-tiene-una-onza-conversiones-marihuana-utiles/">Cu&aacute;ntos Gramos Tiene una Onza y Otras Conversiones Cann&aacute;bicas &Uacute;tiles</a></li>
</ul>

IM Cannabis Gets Into Adult-Use Cannabis Market With Wagners Brand Launch In Canada

MediPharm Labs Corp. (TSX:<a class="ticker" href="https://www.benzinga.com/stock/LABS#TSX">LABS</a>) (OTCQX:<a class="ticker" href="https://www.benzinga.com/stock/MEDIF#OTCQX">MEDIF</a>) (FSE: MLZ) will extend its supply deal with Europe-based medical cannabis company ADREXpharma GmbH.

The Toronto-based company&nbsp;<a href="https://www.benzinga.com/markets/cannabis/19/09/14480625/medipharm-labs-reaches-germany-signs-export-agreement-with-adrexpharma">entered into a private label sales agreement for exports to Europe</a> with the German licensed distributor of medical cannabis and controlled drugs&nbsp;in 2019.

Since then, MediPharm has been providing ADREXpharma with THC and CBD products for sale and distribution under the ADREXpharma brand in Germany.

The deal was renewed for five years, with an option for further extension.

<h3>MediPharm And Medical Cannabis Market In Germany</h3>

MediPharm boosted its presence in Germany by <a href="https://www.benzinga.com/markets/cannabis/20/10/17791321/medipharm-labs-inks-exclusive-supply-agreement-with-germanys-stada">agreeing to supply</a> GMP-certified medical cannabis products to pharmaceutical giant Stada Arzneimittel AG last year and by inking a <a href="https://www.benzinga.com/markets/cannabis/21/04/20646293/im-cannabis-medipharm-labs-sign-supply-agreement-for-german-market">two-year supply agreement </a>with IM Cannabis&rsquo;s (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) subsidiary, Adjupharm GmbH in April.

Over the first quarter of 2021, the company finalized its first shipment of cannabis products to ADREXpharma and is poised to deliver the next one in the second quarter.

&ldquo;With our global platform purpose-built to good manufacturing practices, MediPharm has established a strong foothold in the nascent, but burgeoning, German cannabis market,&rdquo; Keith Strachan, president and Interim CEO of MediPharm, said Tuesday. &ldquo;Our collaboration with ADREX has been an important and strategic step in our growth in this attractive market. We will continue to work together, combining ADREX&rsquo;s experience and local networks with our licenses, production, and supply chain capabilities, to ensure German patients gain access to the high-quality cannabis products they can trust.&rdquo;

As the largest medical cannabis market in Europe, Germany&#39;s patient base&nbsp;has grown to 128,000, the company reported, which led to a 34% increase in medical cannabis sales in 2020.

Mario Eimuth, a founding partner at ADREXpharma, said they are &ldquo;excited having launched the first products produced by MediPharm in the growing German market and to expand our international footprint with this strategic collaboration.&rdquo;

Photo by <a href="https://unsplash.com/@exxteban?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Esteban Lopez</a> on <a href="https://unsplash.com/s/photos/cannabis?utm_source=unsplash&amp;utm_medium=referral&amp;utm_content=creditCopyText">Unsplash</a>

MediPharm Labs Extends Collaboration With German Medical Cannabis Distributor ADREXpharma

Israel-based multi-country operator IM Cannabis (CSE:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#CSE">IMCC</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) announced it signed a three-year deal with Canadian licensed producer The FLOWR Corporation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLWPF#OTC">FLWPF</a>), under which the latter will provide its ultra-premium cannabis strains to IM Cannabis for distribution and sale in Israel under the IMC brand.&nbsp;

Oren Shuster, CEO of IM Cannabis said in a statement to Benzinga that, &ldquo;As the Israeli medical cannabis market continues to expand, demand from patients for premium high-THC products increases. The agreement with FLOWR is another cornerstone in IM Cannabis&#39;&nbsp;growth strategy to enhance its product portfolio in the local market with a new category of indoor ultra-premium offerings.

&ldquo;With the local market expected to boom thanks to the impending legalization supported by the upcoming new government, we will continue to collaborate and partner with leading global cultivators to ensure patients who trust our brand and rely on our products, have access to the highest quality medical cannabis available,&rdquo; Shuster added.

According to IM Cannabis, the first shipment of the FLOWR strains is expected to be available to Israeli patients during the second half of 2021 and distributed through licensed pharmacies, including IM Cannabis&rsquo; online pharmacy and distribution network it acquired recently from Panaxia

Encuentra nuestro contenido en Espa&ntilde;ol en El Planteo:

<ul>
	<li><a href="https://elplanteo.com/que-es-el-thc/">B&aacute;sicos del Cannabis: &iquest;Qu&eacute; Es el THC?</a></li>
	<li><a href="https://elplanteo.com/cepas-de-marihuana-sour-diesel/">Cepas de Marihuana: Sour Diesel</a></li>
	<li><a href="https://elplanteo.com/como-hacer-una-desintoxicacion-de-thc/">C&oacute;mo Hacer una Desintoxicaci&oacute;n de THC</a></li>
</ul>

IM Cannabis, FLOWR Sign Multi-Year Deal To Import Medical Marijuana From Canada To Israel

Alliance Global Partners analyst Aaron Grey initiates coverage on IM Cannabis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMCC#NASDAQ">IMCC</a>) with a Buy rating and announces Price Target of $10.

Recent Quotes

Related Companies

IM Cannabis Frequently Asked Questions

How do I buy IM Cannabis (IMCC) stock?

Who are IM Cannabis's (IMCC) competitors?

What is the target price for IM Cannabis (IMCC) stock?

Current Stock Price for IM Cannabis (IMCC)?

Does IM Cannabis (IMCC) pay a dividend?

When is IM Cannabis (NASDAQ:IMCC) reporting earnings?

Is IM Cannabis (IMCC) going to split?

What sector and industry does IM Cannabis (IMCC) operate in?